Only 10 Japanese CNC cases, including our case, have received the PRKAR1A genetic test, and most of them were recent, between 2013 and 2017, indicating that the genetic test has not been widespread in clinical practice.
There is a small body of literature examining the relationship between HRQoL and genetic testing in the LS population.
As such, the proposed connection between advanced genetic testing and health prevention evokes both concern and optimism: '—There are both growing concerns and growing excitement at the same time.
These findings provide possible explanations for the time frames between genetic testing and risk-reducing surgeries observed in other studies [ 6- 9].
[4] Another important difference between clinical genetic testing and PGT is that consumers can purchase PGT without direct input from medical professionals.
Hundreds of agreements have been signed between genetic testing firms and US payers that have apparently not required disclosure of the underlying data, which is ultimately derived from – and would benefit – patients seeking optimal treatment.
Due to the aforementioned differences between PGT and clinical genetic testing, findings from attitudinal studies in clinical genetics cannot be directly transposed to PGT.
The weaker the scientific foundation is for a hypothesized relationship between a genetic test and an environmental disease, the weaker the moral argument to violate a child's genetic privacy rights.
On the other hand, large genomic rearrangements are not detectable by current PCR-based methods, perhaps explaining the discrepancy between linkage analysis and genetic testing.
Interview studies assessing attitudes among adults diagnosed with cancer toward personalized medicine revealed that a majority of participants expressed understanding of the difference between germline and somatic genetic testing based on descriptions provided to them.
